Eli Lilly's stock dipped due to cutting Q4 sales targets, despite a strong 2024 performance from Mounjaro and Zepbound. Click ...

Following a rough fourth quarter, we see the healthcare sector overall as undervalued, with a median discount to our fair ...

S&P 500 E-Mini futures (ESH25) are trending up +0.16% this morning as investors looked ahead to key U.S. inflation data and ...

Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...

There's still a lot to like about Eli Lilly stock, an analyst said Wednesday after the weight-loss drugs kingpin cut its sales view.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Spain’s Almirall has announced strategic plans at the 43rd JP Morgan Healthcare Conference based on expected double-digit growth within the dermatological area for Almirall’s psoriasis and atopic ...

Undervalued biotech company Regenxbio Inc. shows promise with cutting-edge gene therapy technology for AMD and MPS II. Click ...

Wall Street stocks rose after in the bell in New York after US inflation climbed last month according to official figures.

PM when the US CPI data will be released, expected at +XNUMX%. Any move away from that level could cause shocks on the markets. In Asia, the strong injection of liquidity into China for the New Year ...